[English] 日本語
Yorodumi- PDB-8xlq: FGFR4 kinase domain with a dual-warhead covalent inhibitor CXF-007 -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 8xlq | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | FGFR4 kinase domain with a dual-warhead covalent inhibitor CXF-007 | |||||||||
Components | Fibroblast growth factor receptor 4 | |||||||||
Keywords | TRANSFERASE/INHIBITOR / Fibroblast growth factor receptor 4 / TRANSFERASE / TRANSFERASE-INHIBITOR complex | |||||||||
| Function / homology | Function and homology informationFGFR4 mutant receptor activation / betaKlotho-mediated ligand binding / regulation of extracellular matrix disassembly / positive regulation of catalytic activity / phosphate ion homeostasis / regulation of bile acid biosynthetic process / FGFR4 ligand binding and activation / Phospholipase C-mediated cascade; FGFR4 / fibroblast growth factor receptor activity / positive regulation of DNA biosynthetic process ...FGFR4 mutant receptor activation / betaKlotho-mediated ligand binding / regulation of extracellular matrix disassembly / positive regulation of catalytic activity / phosphate ion homeostasis / regulation of bile acid biosynthetic process / FGFR4 ligand binding and activation / Phospholipase C-mediated cascade; FGFR4 / fibroblast growth factor receptor activity / positive regulation of DNA biosynthetic process / PI-3K cascade:FGFR4 / fibroblast growth factor binding / regulation of lipid metabolic process / positive regulation of proteolysis / PI3K Cascade / fibroblast growth factor receptor signaling pathway / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / transport vesicle / FRS-mediated FGFR4 signaling / peptidyl-tyrosine phosphorylation / cholesterol homeostasis / Negative regulation of FGFR4 signaling / receptor protein-tyrosine kinase / Constitutive Signaling by Aberrant PI3K in Cancer / cell migration / glucose homeostasis / PIP3 activates AKT signaling / heparin binding / protein autophosphorylation / PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling / RAF/MAP kinase cascade / positive regulation of ERK1 and ERK2 cascade / receptor complex / endosome / positive regulation of cell population proliferation / positive regulation of gene expression / endoplasmic reticulum / Golgi apparatus / extracellular region / ATP binding / plasma membrane Similarity search - Function | |||||||||
| Biological species | Homo sapiens (human) | |||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.95 Å | |||||||||
Authors | Chen, X.J. / Chen, Y.H. | |||||||||
| Funding support | China, 2items
| |||||||||
Citation | Journal: Eur.J.Med.Chem. / Year: 2024Title: Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4. Authors: Chen, X. / Li, H. / Lin, Q. / Dai, S. / Qu, L. / Guo, M. / Zhang, L. / Liao, J. / Wei, H. / Xu, G. / Jiang, L. / Chen, Y. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 8xlq.cif.gz | 81.5 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb8xlq.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 8xlq.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 8xlq_validation.pdf.gz | 784.3 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 8xlq_full_validation.pdf.gz | 787.8 KB | Display | |
| Data in XML | 8xlq_validation.xml.gz | 15.6 KB | Display | |
| Data in CIF | 8xlq_validation.cif.gz | 22.3 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/xl/8xlq ftp://data.pdbj.org/pub/pdb/validation_reports/xl/8xlq | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 8xloC ![]() 7v29S S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 34695.059 Da / Num. of mol.: 1 / Fragment: kinase domain Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: FGFR4, JTK2, TKF / Production host: ![]() References: UniProt: P22455, receptor protein-tyrosine kinase | ||||||
|---|---|---|---|---|---|---|---|
| #2: Chemical | ChemComp-A1LVQ / Mass: 619.670 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C34H33N7O5 / Feature type: SUBJECT OF INVESTIGATION | ||||||
| #3: Chemical | | #4: Water | ChemComp-HOH / | Has ligand of interest | Y | Has protein modification | Y | |
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.23 Å3/Da / Density % sol: 44.84 % |
|---|---|
| Crystal grow | Temperature: 277.15 K / Method: vapor diffusion, hanging drop Details: 0.1 M Bis-Tris (pH 4.5), 0.2 M Li2SO4, 16-20% PEG3350 |
-Data collection
| Diffraction | Mean temperature: 80 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: SSRF / Beamline: BL17U / Wavelength: 0.97918 Å |
| Detector | Type: ADSC QUANTUM 315r / Detector: CCD / Date: Nov 24, 2019 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 0.97918 Å / Relative weight: 1 |
| Reflection | Resolution: 1.95→60.47 Å / Num. obs: 22227 / % possible obs: 99.24 % / Redundancy: 6.3 % / Biso Wilson estimate: 27.73 Å2 / CC1/2: 0.996 / Rmerge(I) obs: 0.08815 / Net I/σ(I): 14.1 |
| Reflection shell | Resolution: 1.95→2.02 Å / Redundancy: 4.3 % / Rmerge(I) obs: 0.554 / Mean I/σ(I) obs: 2.47 / Num. unique obs: 2210 / CC1/2: 0.876 / % possible all: 97.91 |
-
Processing
| Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 7V29 Resolution: 1.95→60.468 Å / SU ML: 0.21 / Cross valid method: THROUGHOUT / σ(F): 1.35 / Phase error: 25.53 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 103.93 Å2 / Biso mean: 36.4847 Å2 / Biso min: 16.29 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 1.95→60.468 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
X-RAY DIFFRACTION
China, 2items
Citation

PDBj








